Skip to main content
SpringerLink
Log in

Neonatal hyperbilirubinaemia: early detection and appropriate treatment prevent kernicterus

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Isselbacher KJ. Bilirubin metabolism and hyperbilirubinemia. In: Wilson JD, et al., editors. Harrison’s principles of internal medicine. 12th ed. New York: McGraw-Hill, 1991: 1317–22

    Google Scholar 

  2. Rubaltelli FF. Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus. Drugs 1998 Jul; 56(1): 23–30

    Article  PubMed  CAS  Google Scholar 

  3. Grunebaum E, Amir J, Merlob P, et al. Breast milk jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant. Eur J Pediatr 1991; 150: 267–70

    Article  PubMed  CAS  Google Scholar 

  4. Olds SB, London ML, Ladewig PW. Maternal-newborn nursing: a family-centered approach. Menlo Park (CA): Addison-Wesley Nursing, 1996: 1019–30

    Google Scholar 

  5. Rubaltelli FF, Griffith PF. Management of neonatal hyperbilirubinaemia and prevention of kernicterus. Drugs 1992 Jun; 43(6): 864–72

    Article  PubMed  CAS  Google Scholar 

  6. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995; 96: 730–3

    PubMed  CAS  Google Scholar 

  7. Keenan WJ, Novak KK, Sutherland JM, et al. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75 Suppl.: 417–21

    PubMed  CAS  Google Scholar 

  8. Kappas A, Drummond GS, Henschke C, et al. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995; 95: 468–74

    PubMed  CAS  Google Scholar 

  9. Kimura M, Matsumura Y, Miyauchi Y, et al. A new tactic for the treatment of jaundice: an injectable polymer-conjugated bilirubin oxidase. Proc Soc Exp Biol Med 1988; 188: 364–9

    PubMed  CAS  Google Scholar 

  10. Johnson L, Gourley G, Kreamer W, et al. Bilirubin oxidase (box) was non-toxic, decreased stool bilirubin products and retained activity in stools during 22 days of feeding to four children with Crigler Najjar syndrome (cn) aged 3 to 7 years [abstract]. Pediatr Res 1996; 39: 219A

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neonatal hyperbilirubinaemia: early detection and appropriate treatment prevent kernicterus. Drugs Ther. Perspect 13, 11–14 (1999). https://doi.org/10.2165/00042310-199913100-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199913100-00004

Keywords

Search

Navigation